[Local administration of danazol on pelvic endometriosis and uterine adenomyosis].

M Igarashi, M Fukuda, Masaki Fukuda, A Ando, Akihiko Ando, M Miyasaka, Makihiro Miyasaka, H Taguchi, Megumi Yoshida, M Yoshida, Y Abe, Yumiko Abe
Nihon rinsho. Japanese journal of clinical medicine · 2001 · vol. 59 Suppl 1 , pp. 153–6 · PMID:11235155 · W2410706559
article OA: closed CC0 ⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

Local danazol administration improved pelvic endometriosis and uterine adenomyosis symptoms by reducing lesion size and inflammation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosisadenomyosis

MeSH descriptors

Danazol Endometriosis Estrogen Antagonists Administration, Intravaginal Danazol Endometriosis Estrogen Antagonists Female Humans Intrauterine Devices, Medicated

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:13:30.513821+00:00
License: CC0 · commercial use OK